Scientists have discovered compelling evidence for the cytoprotective and proregenerative effects of a neuropeptide in promoting corneal healing after eye injury.

A Phase 3 trial for an ophthalmic solution for treating patients with night vision disturbances is expected to begin soon.

World Optometry Week, from 17–23 March, will be themed ‘Advancing optometry’s commitment to global eye care’.

Practical, low-cost initiatives have been recommended to maximise Australia’s eye health in a pre-budget submission prepared by Optometry Australia.